CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Defined Benefit Plan, Benefit Obligation, Business Combination
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Defined Benefit Plan, Benefit Obligation, Business Combination of $0 for the 12-month period ending 2024-12-28, per its 10-K filed 2025-02-19.
Financial Statements › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Roll Forwards
us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation · last filed 2025-02-19
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, benefit obligation, business combination for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, benefit obligation, business combination for fiscal 2023 was $1.11M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, benefit obligation, business combination for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, benefit obligation, business combination for fiscal 2021 was $11.96M.
| Period end | Defined Benefit Plan, Benefit Obligation, Business Combination 12 month | Defined Benefit Plan, Benefit Obligation, Business Combination 12 month as first filed |
|---|---|---|
| 2024-12-28 | $0.00 10-K · filed 2025-02-19 | |
| 2023-12-30 | $1.11M 10-K · filed 2025-02-19 | |
| 2022-12-31 | $0.00 10-K · filed 2024-02-14 | |
| 2021-12-25 | $11.96M 10-K · filed 2023-02-22 | -$11.96M 10-K · filed 2022-02-16 |
| 2020-12-26 | $0.00 10-K · filed 2022-02-16 | |
| 2019-12-28 | $6.82M 10-K · filed 2021-02-17 | |
| 2018-12-29 | $0.00 10-K · filed 2020-02-11 | |
| 2017-12-30 | $0.00 10-K · filed 2018-02-13 | |
| 2016-12-31 | $5.27M 10-K · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |